Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 197-210 , September 2009

A review of counseling practices on prescription medicines in community pharmacies

  • Hanni Prihhastuti Puspitasari, B.Sc., (M.Phil. candidate)

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +61 2 9351 4445; fax: +61 2 9351 4391.
    • ,
  • Parisa Aslani, B.Pharm. (Hons) M.Sc., Ph.D., Grad. Cert. Ed. Stud. (Higher Ed.)
    • ,
  • Ines Krass, B.Pharm. Dip.Hosp. Pharm. Grad. Dip. Educ. Studies (Health Ed.) Ph.D

References 

  1. Rantucci MJ. Pharmacists Talking With Patients: A Guide To Patient Counseling. 2nd ed. Philadelphia: Lippincott Williams & Wilkins; 2007;
  2. Chandra A, Malcolm N, Fetters M. Practising health promotion through pharmacy counseling activities. Health Promot Pract. 2003;4:64–71
  3. Wu JYF, Leung WYS, Chang S, Lee B, Zee B, et al. Effectiveness of telephone counselling by a pharmacist in reducing mortality in patients receiving polypharmacy: Randomised controlled trial. BMJ. 2006;333(7567):522–525
  4. Liu MY, Jenning JP, Samuelson WM, Sullivan CA, Veltri JC. Asthma patients' satisfaction with the frequency and content of pharmacist counselling. J Am Pharm Assoc. 1999;39:493–498
  5. Ebid AH, Abdel-Wahab E. Bronchial asthma and COPD: Impact of pharmaceutical care on outcomes and quality of life in Egyptian patients. Bulletin of Pharmaceutical Sciences. 2006;29:167–185
  6. Morrow N, Hargie O, Woodman C. Consumer perceptions of and attitudes to the advice-giving role of community pharmacists. Pharm J. 1993;251:25–27
  7. Kansanaho H, Isonen-Sjolund N, Pietila K, Airaksinen M, Isonen T. Patient counselling profile in a Finnish pharmacy. Patient Educ Couns. 2002;47:77–82
  8. Aslanpour Z, Smith FJ. Oral counselling on dispensed medication: A survey of its extent and associated factors in a random sample of community pharmacies. Int J Pharm Pract. 1997;5:57–63
  9. Tully MP, Hassell K, Noyce PR. Advice giving in community pharmacies in the UK. J Health Serv Res Policy. 1997;2:38–50
  10. Rees PA. Counselling and pharmacists. Pharm J. 1996;257:659
  11. Lam P, Krass I. Prescription-related counselling: what information do you offer?. Aust Pharm. 1995;14:342–347
  12. Krass I. A comparison of clients' experiences of counselling for prescriptions and over-the-counter medications in two types of pharmacies: validation of a research instrument. J Soc Admin Pharm. 1996;13:206–214
  13. Royal Pharmaceutical Society of Great Britain. Medicines, ethics and practice, No. 31. Available at: http://www.rpsgb.org.uk(Accessed Apr 28, 2008)
  14. Schommer JC, Sullivan DL, Wiederholt JB. Comparison of methods used for estimating pharmacist counseling behaviors. J Pharm Technol. 1994;10:261–268
  15. Public Law 101-508. Omnibus Budget Reconciliation Act of 1990. Available at: http://www.indianamedicaid.com/ihcp/PharmacyServices/pdf/what/omnibus.pdf1992;(Accessed 2007 Apr 10)
  16. Pharmaceutical Society of Australia. Guidelines for pharmacists on providing medicines information to patients. In: Australian Pharmaceutical Formulary and Handbook. 20th ed. Canberra: PSA; 2006. p. 365-368.
  17. USP medication counselling behaviour guidelines. Available at: http://www.ipsf.org(Accessed 2007 Apr 4)
  18. ASHP guidelines on pharmacist-conducted patient counselling. Am J Hosp Pharm. 1993;50:505–506
  19. American Society of Consultant Pharmacists. Guidelines for pharmacist counseling of geriatric patients . Available at: http://www/ascp/com1998;(Accessed 2007 Apr 11)
  20. European Commission. Council Directive 92/27/EEC on the Labelling Of Medicinal Products For Human Use And On Package Leaflets. Brussels: European Commission; 1992;
  21. Food and Drug Administration . Guidance for useful written Consumer Medication Information (CMI). Available at: http://www.fda.gov/cder/guidance/7139fnl.pdf2006;(Accessed 2007 Apr 20)
  22. Pharmaceutical Society of Australia. Guidelines: Consumer Medicines Information and the pharmacist. In: Australian Pharmaceutical Formulary and Handbook. 20th ed. Canberra: PSA; 2006. p. 369-370.
  23. Evans S, John DN. A preliminary investigation of the interactions between UK and US community pharmacists and their prescription clients. Int J Pharm Pract. 1995;3:157–162
  24. Krska J, Kennedy EJ, Milne SA, McKessack KJ. Frequency of counselling on prescription medicines in community pharmacy. Int J Pharm Pract. 1995;3:178–185
  25. Savage IT. Time for customer contact in pharmacies with and without a dispensing technician. Int J Pharm Pract. 1995;3:193–199
  26. Morris LA, Tabak ER, Gondek K. Counseling patients about prescribed medication: 12-year trends. Med Care. 1997;35:996–1007
  27. Erickson SR, Kirking DM, Sandusky M. Michigan Medicaid recipients' perceptions of medication counseling as required by OBRA ’90. J Am Pharm Assoc. 1998;38:333–338
  28. Schommer JC, Wiederholt JB. Pharmacists' perceptions of patients' needs for counselling. Am J Hosp Pharm. 1994;51:478–485
  29. Schommer JC, Wiederholt JB. Pharmacists' views of patient counseling. Am Pharm. 1994;46–53NS34
  30. Rumore MM, Felfer S, Rumore JS. New York City pharmacists and OBRA ’90: One year later. Am Pharm. 1995;NS35:29–3466
  31. Pugh CB. Pre-OBRA '90 Medicaid survey: How community pharmacy practice is changing. Am Pharm. 1995;NS35:17–23
  32. Barnes JM, Riedlinger JE, McCloskey WW, Montagne M. Barriers to compliance with OBRA ’90 regulations in community pharmacies. Ann Pharmacother. 1996;30:1101–1105
  33. Scott DM, Wessels MJ. Impact of OBRA ’90 on pharmacists' patient counseling practices. J Am Pharm Assoc. 1997;401–406NS37
  34. Praska JL, Kripalani S, Seright AL, Jacobson TA. Identifying and assisting low-literacy patients with medication use: A survey of community pharmacies. Ann Pharmacother. 2005;39:1441–1445
  35. Allan EL, Barker KN, Malloy MJ, Heller WM. Dispensing errors and counseling in community pharmacies. Am Pharm. 1995;25–33NS35
  36. Schatz R, Belloto RJJ, White DB, Bachmann K. Provision of drug information to patients by pharmacists: The impact of the omnibus budget reconciliation act of 1990 a decade later. Am J Ther. 2003;10:93–103
  37. Svarstad BL, Bultman DC, Mount JK. Patient counseling provided in community pharmacies: Effects of state regulation, pharmacist age, and busyness. J Am Pharm Assoc. 2004;44:22–29
  38. Schommer J. Effect of interrole congruence on pharmacist-patient communication. Health Communication. 1994;6:297–309
  39. Sleath B. Pharmacist question-asking in New Mexico community pharmacies. Am J Pharm Educ. 1995;59:374–379
  40. Sleath B. Pharmacist-patient relationships: Authoritarian, participatory or default?. Patient Educ Couns. 1996;28:253–263
  41. Schommer JC, Wiederholt JB. A field investigation of participant and environment effects on pharmacist-patient communication in community pharmacies. Med Care. 1995;33:567–584
  42. Schommer JC, Wiederholt JB. The association of prescription status, patient age, patient gender, and patient question asking behavior with the content of pharmacist-patient communication. Pharm Res. 1997;14:145–151
  43. Raisch DW. Patient counseling in community pharmacy and its relationship with prescription payment methods and practice setting. Ann Pharmacother. 1993;27:1173–1179
  44. Perri M, Kofzan J, Pritchard L, Ozburn W, Francisco G. OBRA ’90: The impact on pharmacists and patients. Am Pharm. 1995;24–28NS35
  45. Fritsch MA, Lamp KC. Low pharmacist counseling rates in the Kansas City, Missouri, metropolitan area. Ann Pharmacother. 1997;31:984–991
  46. Livingstone CR, Pugh ALG, Winn S, Williamson VK. Developing community pharmacy services wanted by local people: Information and advice about prescription medicines. Int J Pharm Pract. 1996;4:94–101
  47. Blom ATG, Kam AL, Bakker A, Claesson C. Patient counselling in community pharmacy: Comparative study between Swedish and Dutch pharmacists. J Soc Admin Pharm. 1993;10:53–62
  48. Vainio KK, Pennanen M, Tuomainen L, Enlund H. Views of pharmacists on asthma patients and their counselling. J Appl Ther Res. 1998;2:49–58
  49. Osman NM, Bond CM, Mackenzie J, Williams S. Asthma advice giving by community pharmacy. Int J Pharm Pract. 1999;7:12–17
  50. Pronk M, Blom L, Jonkers R, Rogers EM, Bakker A, de Blaey KJ. Patient oriented activities in Dutch community pharmacy: Diffusion of innovations. Pharm World Sci. 2002;24:154–161
  51. Livingstone CR. Verbal interactions between elderly people and community pharmacists about prescriptions medicines. Int J Pharm Pract. 1996;4:12–18
  52. Savage IT. Observing pharmacists at work: Quantifying the Hawthorne effect. J Soc Admin Pharm. 1996;13:8–19
  53. Hassell K, Noyce PR, Rogers A, Harris J, Wilkinson J. Advice provided in British community pharmacies: what people want and what they get. J Health Serv Res Policy. 1998;3:219–225
  54. Blom L, Jonkers R, Kok G, Bakker A. Patient education in 20 Dutch community pharmacies: Analysis of audiotaped patient contacts. Int J Pharm Pract. 1998;6:72–76
  55. Vainio KK, Airaksinen MSA, Hyykky TT, Enlund KH. Effect of therapeutic class on counseling in community pharmacies. Ann Pharmacother. 2002;36:781–786
  56. Basheti IA, Reddel HK, Armour C, Bosnic-Anticevich SZ. Counselling about turbuhaler technique: Needs assessment and effective strategies for community pharmacists. Respir Care. 2005;50:617–623
  57. Willison DJ, Muzzin LJ. Workload, data gathering, and quality of community pharmacist's advice. Med Care. 1995;33:29–40
  58. Moser CA, Kalton G. Survey Methods in Social Investigation. 2nd ed.. Aldershot, England: Dartmouth; 1993;
  59. Smith FJ. Health services research methods in pharmacy: triangulation. Int J Pharm Pract. 1999;7:60–68
  60. Watson MC, Norris PT, Granas AG. A systematic review of the use of simulated patients and pharmacy practice research. Int J Pharm Pract. 2006;14:83–93
  61. Hugtenburg JG, Blom ATG, Gopie CTW, Beckeringh JJ. Communicating with patients the second time they present their prescription at the pharmacy. Pharm World Sci. 2004;26:328–332
  62. Laaksonen R, Duggan C, Bates I. Desire for information about drugs relationships with patients' characteristics and adverse effects. Pharm World Sci. 2004;24:205–210
  63. Koo M, Krass I, Aslani P. Consumer use of consumer medicine information. J Pharm Pract Res. 2005;35:94–98
  64. Koo M, Krass I, Aslani P. The use of CMI by consumers. Aust J Pharm. 2001;82:18
  65. Dickinson D, Raynor DK. Ask the patients—they may want to know more than you think. BMJ. 2003;327:861
  66. Nair K, Dolovich L, Cassels A, McCormack J, Levine M, et al. What patients want to know about their medications: Focus group study of patient and clinician perspectives. Can Fam Physician. 2002;48:104–110
  67. Zieger DK, Mosier M, Buenaver BS, Okuyemi K. How much information about adverse effects of medication do patients want from physicians. Arch Intern Med. 2001;161:706–713
  68. Myers ED, Calvert EJ. Information, compliance and side effect: a study of patients on antidepressant medication. Br J Clin Pharmac. 1984;17:21–25

PII: S1551-7411(08)00092-2

doi: 10.1016/j.sapharm.2008.08.006

Research in Social and Administrative Pharmacy
Volume 5, Issue 3 , Pages 197-210 , September 2009

Article Tools